PharmaBoardroom

Interview with Ewe Kheng Huat, Managing Director, Merck Sharp…

Stefan Oschmann, President of the Emerging Markets at Merck and Co. described MSD as the dark horse of the emerging markets. How is MSD performing in…

Interview with Jeh Ping Chang, General Manager, OEP Philippines

Mr. Chang, can you please give an overview of the establishment of OEP Philippines and the company’s current activities here? OEP Philippines…

Interview with Martin Nelzow, CEO, Boehringer Ingelheim Brazil

You came to Boehringer Ingelheim in 2009 – what are some of the most exciting milestones and achievements you have presided over during this…

Interview with Rafael Hizon, Chief Executive Officer, Hizon…

Hizon Laboratories has been present in the Philippines for more than a century and several generations of Hizon have been at the head of the company.…

Interview with Jose Antonio Alas, President, Eli Lilly do Brasil

An important topic in Brazil is access to drugs. In recent interviews we have spoken about a third of MS patients being treated, or 10% of…

Interview with Jan Wisse, Managing Director, Niaba

The Netherlands is famous throughout Europe and the global pharmaceutical community for its research infrastructure – institutes, university…

Interview with Rubens Pedrosa, President, AstraZeneca Brazil

What have been some of the recent milestones and achievements contributing to AstraZeneca Brazil’s status as the country’s fastest growing…

Interview with Roberto Alvarenga, General Manager, Ferring…

Yesterday the Ministry of Health released an article stating that chronic diseases now account for 70% of all deaths in Brazil, and welcoming…

Interview with Roland Zegger, Chairman of the Pharmaceutical…

Given the peculiarities of the pharmaceutical industry in the Netherlands, such as the highest generics penetration rate in Europe, a relatively small…